FDA-ClearedStrong EvidenceENT

Sudden Sensorineural Hearing Loss

ISSNHL is a rapid hearing loss with no identifiable cause. The cochlea has extremely high oxygen demands. HBOT increases oxygen delivery, reduces cochlear edema, and may improve hair cell recovery, especially within 14 days of onset.

Typical Protocol at a Glance

Pressure

2.4 ATA

Duration

90 min

Sessions

Protocols

Treatment protocols with pressure, duration, and session details

1 items

Studies

PubMed research links, summaries, and evidence limitations

2 items

Testimonials

Patient experiences and outcomes

1 items

Monitoring

Recommended labs, imaging, and diagnostic tests

5 items

Supplements

Supportive supplements with dosing guidance

5 items

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.